J0220 HCPCS Level II code: Injection, alglucosidase alfa, 10 mg, not otherwise specified
J0220 is the HCPCS code for “Injection, alglucosidase alfa, 10 mg, not otherwise specified” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0220Injection, alglucosidase alfa, 10 mg, not otherwise specified
Short description: Alglucosidase alfa injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J0220 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2008
Where J0220 sits
- 1J codesDrugs administered other than orally
- 2Active code J0220Injection, alglucosidase alfa, 10 mg, not otherwise specified
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0220 mean?
J0220 is the HCPCS code for “Injection, alglucosidase alfa, 10 mg, not otherwise specified” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0220?
CMS lists J0220’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0220
All J codesJ0211Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)J0215Injection, alefacept, 0.5 mgJ0216Injection, alfentanil hydrochloride, 500 microgramsJ0217Injection, velmanase alfa-tycv, 1 mgJ0218Injection, olipudase alfa-rpcp, 1 mgJ0219Injection, avalglucosidase alfa-ngpt, 4 mgJ0221Injection, alglucosidase alfa, (lumizyme), 10 mgJ0222Injection, patisiran, 0.1 mgJ0223Injection, givosiran, 0.5 mgJ0224Injection, lumasiran, 0.5 mgJ0225Injection, vutrisiran, 1 mgJ0248Injection, remdesivir, 1 mg